Seeing Is Believing
Healthcare - Sector
with an average price target of $3.49. This is a potential upside of $-9.73 (-73.6%) from yesterday's end of day stock price of $13.22.
Magenta Therapeutics's activity chart (see below) currently has 13 price targets and 11 ratings on display.
Analysts average stock forecasts to be materialized ratio is 68.52% with an average time for these price targets to be met of 154.56 days.
Most recent stock forecast was given by YUN ZHONG from BTIG on 26-Jan-2023. First documented stock forecast 25-Mar-2019.
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 26-Jan-2023
$3
2 years 11 months 16 days ago
(26-Jan-2023)
2/3 (66.67%)
$-2.8 (-48.28%)
266
Buy
Since 08-Mar-2022
$3
$-8.19 (-73.19%)
$9
2 years 11 months 16 days ago
(26-Jan-2023)
1/2 (50%)
$-4.04 (-57.39%)
287
Hold
$2
$1.3 (185.71%)
$7
3 years 4 months 17 days ago
(25-Aug-2022)
1/3 (33.33%)
$0.13 (6.95%)
14
Buy
Since 18-Apr-2022
$8
$-3.19 (-28.51%)
3 years 8 months 24 days ago
(18-Apr-2022)
1/1 (100%)
$-22.72 (-73.96%)
246
Buy
Since 18-Apr-2022
$8
$-3.19 (-28.51%)
$17
3 years 8 months 24 days ago
(18-Apr-2022)
2/2 (100%)
$-22.72 (-73.96%)
137
What is MGTA (Magenta Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MGTA (Magenta Therapeutics) with a proven track record?
Which analyst has the current lower performing score on MGTA (Magenta Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MGTA (Magenta Therapeutics)?
Which analyst is the currently most bullish on MGTA (Magenta Therapeutics)?
Which analyst is the currently most reserved on MGTA (Magenta Therapeutics)?